Article Text
Abstract
A group of activist clinicians have offered to volunteer for clinical trials of live attenuated HIV vaccines. This has provided an important conceptual challenge to medical ethics, and to work on the development of HIV vaccines. In exploring these issues, this article highlights how the HIV field has altered the content as well as the tone of ethical discourse. The balance of expertise and authority between research subjects and triallists is profoundly changed, raising questions about the limits of voluntarism and differing perspectives on risk-benefit analysis. Care is needed to ensure that the novelty of the situation does not confuse the central ethical and scientific issues.
- HIV vaccines
- research ethics
- risk-benefit analysis
- voluntarism
- consent
Statistics from Altmetric.com
Footnotes
-
Anthony J Pinching is Louis Freedman Professor of Immunology and Fellow, Department of Human Science and Medical Ethics, St Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary & Westfield College, West Smithfield, London EC1A 7BE.
Read the full text or download the PDF:
Other content recommended for you
- Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
- Doctors volunteer to be guinea pigs for AIDS vaccine
- Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine
- First trial of the HIV-1 vaccine in Africa: Ugandan experience
- Exploring the ethics of tuberculosis human challenge models
- Quest for the AIDS vaccine
- Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines
- The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens
- Where now for AIDS vaccines?
- Vaccines in the 21st century